Capricor Therapeutics (CAPR) EBITDA Margin Growth (3y) (2014 - 2024)
Capricor Therapeutics (CAPR) EBITDA Margin Growth (3y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
204,463.00 |
| Mar 31, 2024 |
1.26 Mn |
| Dec 31, 2023 |
725,738.00 |
| Sep 30, 2023 |
2.30 Mn |
| Jun 30, 2023 |
683,321.00 |
| Mar 31, 2023 |
86,974.00 |
| Dec 31, 2022 |
-14,271.00 |
| Sep 30, 2022 |
73,501.00 |
| Jun 30, 2021 |
-131,169.00 |
| Mar 31, 2021 |
-1.18 Mn |
| Dec 31, 2020 |
-984,951.00 |
| Sep 30, 2020 |
-2.23 Mn |
| Jun 30, 2020 |
-590,856.00 |
| Mar 31, 2020 |
-71,532.00 |
| Dec 31, 2019 |
-35,931.00 |
| Sep 30, 2019 |
731,607.00 |
| Jun 30, 2019 |
1,556.00 |
| Mar 31, 2019 |
-61,583.00 |
| Dec 31, 2018 |
-37,799.00 |
| Sep 30, 2018 |
-166,458.00 |
